Therapeutic properties of cannabinoid drugs and marijuana in several disorders. A narrative review of the literature

被引:1
作者
Nanni Alvarado, Ricardo Ivan [1 ,2 ]
del Campo Sanchez, Raul Martin [2 ,3 ]
Villamil Salcedo, Valerio [4 ]
机构
[1] CENADIC, Direcc Gen Adjunta Polit, Ave Paseo Reforma 450,Piso 8, Mexico City 06600, DF, Mexico
[2] CENADIC, Programas Adicc, Ave Paseo Reforma 450,Piso 8, Mexico City 06600, DF, Mexico
[3] CENADIC, Direcc Gen Polit, Mexico City, DF, Mexico
[4] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Invest Clin, Mexico City, DF, Mexico
关键词
Marijuana plant; cannabinoid drugs; therapeutic effects; preclinical and clinical studies; evidence-based medicine; health policy; DOUBLE-BLIND CROSSOVER; RANDOMIZED CONTROLLED-TRIAL; CHEMOTHERAPY-INDUCED NAUSEA; CONTROLLED CLINICAL-TRIAL; MULTIPLE-SCLEROSIS; PHASE-III; DELTA(9)-TETRAHYDROCANNABINOL THC; ENDOCANNABINOID SYSTEM; CANCER-CHEMOTHERAPY; NABILONE;
D O I
10.17711/SM.0185-3325.2017.014
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background. Anti-inflammatory, analgesic, anticonvulsant, and other effects have been attributed to cannabis, and so it has been widely used to treat several diseases. Objective. To assess the use and therapeutic effects of cannabinoid drugs and the cannabis plant in several diseases. Method. We carried out a narrative review of the literature that has reported the use of the cannabis plant (marijuana) and cannabinoid drugs (nabilone, cannabinol and dronabinol, among others). We conducted a search in Medline, Cochrane, SciELO and other web sites. Clinical, controlled, double-blind and randomized studies were included. The route of administration and the cannabinoid drugs used were assessed too. Results. Thirty-four studies were included. Nabilone was the cannabinoid drug more commonly used (12 studies), followed by delta-9-tetrahydrocannabinol (THC) (11 studies). It was also found that the marijuana plant and cannabinoid drugs were used to treat many symptoms or diseases. Two studies were reported for Gilles de la Tourette's syndrome. Discussion and conclusion. Many scientific studies on the marijuana plant and cannabinoid drugs conclude that these are not as effective as conventional medications and thus their benefits should be taken with caution.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 61 条
  • [1] Short-term effects of cannabinoids in patients with HIV-1 infection - A randomized, placebo-controlled clinical trial
    Abrams, DI
    Hilton, JF
    Leiser, RJ
    Shade, SB
    Elbeik, TA
    Aweeka, FT
    Benowitz, NL
    Bredt, BM
    Kosel, B
    Aberg, JA
    Deeks, SG
    Mitchell, TF
    Mulligan, K
    Bacchetti, P
    McCune, JM
    Schambelan, M
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (04) : 258 - 266
  • [2] [Anonymous], NETHERLANDS DRUG SIT
  • [3] [Anonymous], 2012, MED TOXICOLOGY DRUG
  • [4] An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy
    Bestard, Jennifer A.
    Toth, Cory C.
    [J]. PAIN PRACTICE, 2011, 11 (04) : 353 - 368
  • [5] Mechanisms of NK cell activation: CD4+ T cells enter the scene
    Bihl, Franck
    Germain, Claire
    Luci, Carmelo
    Braud, Veronique M.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (21) : 3457 - 3467
  • [6] An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis
    Brady, CM
    DasGupta, R
    Dalton, C
    Wiseman, OJ
    Berkley, KJ
    Fowler, CJ
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (04) : 425 - 433
  • [7] Cannabis for dyskinesia in Parkinson disease - A randomized double-blind crossover study
    Carroll, CB
    Bain, PG
    Teare, L
    Liu, X
    Joint, C
    Wroath, C
    Parkin, SG
    Fox, P
    Wright, D
    Hobart, J
    Zajicek, JP
    [J]. NEUROLOGY, 2004, 63 (07) : 1245 - 1250
  • [8] Comision Nacional contra las Adicciones (CONADIC), 2014, US MED CANN IT SUST
  • [9] CRAWFORD SM, 1986, MED ONCOL TUMOR PHAR, V3, P39
  • [10] Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
    Crippa, Jose Alexandre S.
    Derenusson, Guilherme Nogueira
    Ferrari, Thiago Borduqui
    Wichert-Ana, Lauro
    Duran, Fabio L. S.
    Martin-Santos, Rocio
    Simoes, Marcus Vinicius
    Bhattacharyya, Sagnik
    Fusar-Poli, Paolo
    Atakan, Zerrin
    Filho, Alaor Santos
    Freitas-Ferrari, Maria Cecilia
    McGuire, Philip K.
    Zuardi, Antonio Waldo
    Busatto, Geraldo F.
    Cecilio Hallak, Jaime Eduardo
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (01) : 121 - 130